FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015241478> ?p ?o ?g. }

• W2015241478 endingPage "1145" @default.
• W2015241478 startingPage "1139" @default.
• W2015241478 abstract "The association between papillary thyroid cancer (PTC) and Hashimoto's thyroiditis is widely recognized, but less is known about the possible link between circulating anti-thyroglobulin antibody (TgAb) titers and PTC aggressiveness. To shed light on this issue, we retrospectively examined a large series of PTC patients with and without positive TgAb.Data on 220 TgAb-positive PTC patients (study cohort) were retrospectively collected in 10 hospital-based referral centers. All the patients had undergone near-total thyroidectomy with or without radioiodine remnant ablation. Tumor characteristics and long-term outcomes (follow-up range: 2.5-24.8 years) were compared with those recently reported in 1020 TgAb-negative PTC patients with similar demographic characteristics. We also assessed the impact on clinical outcome of early titer disappearance in the TgAb-positive group.At baseline, the study cohort (mean age 45.9 years, range 12.5-84.1 years; 85% female) had a significantly higher prevalence of high-risk patients (6.9% vs. 3.2%, p<0.05) and extrathyroidal tumor extension (28.2% vs. 24%; p<0.0001) than TgAb-negative controls. Study cohort patients were also more likely than controls to have persistent disease at the 1-year visit (13.6% vs. 7.0%, p=0.001) or recurrence during subsequent follow-up (5.8% vs. 1.4%, p=0.0001). At the final follow-up visit, the percentage of patients with either persistent or recurrent disease in the two cohorts was significantly different (6.4% of TgAb-positive patients vs. 1.7% in the TgAb-negative group, p<0.0001). At the 1-year visit, titer normalization was observed in 85 of the 220 TgAb-positive individuals. These patients had a significantly lower rate of persistent disease than those who were still TgAb positive (8.2% vs. 17.3%. p=0.05), and no relapses were observed among patients with no evidence of disease during subsequent follow-up.PTC patients with positive serum TgAb titer during the first year after primary treatment were more likely to have persistent/recurrent disease than those who were consistently TgAb-negative. Negative titers at 1 year may be associated with more favorable outcomes." @default.
• W2015241478 created "2016-06-24" @default.
• W2015241478 creator A5008264035 @default.
• W2015241478 creator A5009821445 @default.
• W2015241478 creator A5009926546 @default.
• W2015241478 creator A5014123674 @default.
• W2015241478 creator A5017766225 @default.
• W2015241478 creator A5027823950 @default.
• W2015241478 creator A5038586420 @default.
• W2015241478 creator A5042156102 @default.
• W2015241478 creator A5043036621 @default.
• W2015241478 creator A5046084794 @default.
• W2015241478 creator A5055086811 @default.
• W2015241478 creator A5068090112 @default.
• W2015241478 creator A5068561297 @default.
• W2015241478 creator A5069110450 @default.
• W2015241478 creator A5075362203 @default.
• W2015241478 creator A5078350860 @default.
• W2015241478 creator A5085467485 @default.
• W2015241478 date "2014-07-01" @default.
• W2015241478 modified "2023-09-27" @default.
• W2015241478 title "Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies" @default.
• W2015241478 cites W1569806610 @default.
• W2015241478 cites W1963592300 @default.
• W2015241478 cites W1980807658 @default.
• W2015241478 cites W1986341655 @default.
• W2015241478 cites W1986802964 @default.
• W2015241478 cites W1999758442 @default.
• W2015241478 cites W2017629947 @default.
• W2015241478 cites W2019014309 @default.
• W2015241478 cites W2025383284 @default.
• W2015241478 cites W2027591337 @default.
• W2015241478 cites W2034479038 @default.
• W2015241478 cites W2039611880 @default.
• W2015241478 cites W2059074720 @default.
• W2015241478 cites W2061615766 @default.
• W2015241478 cites W2065872939 @default.
• W2015241478 cites W2067095180 @default.
• W2015241478 cites W2092359676 @default.
• W2015241478 cites W2097164678 @default.
• W2015241478 cites W2116542352 @default.
• W2015241478 cites W2117776179 @default.
• W2015241478 cites W2143527243 @default.
• W2015241478 cites W2145240320 @default.
• W2015241478 cites W2147085484 @default.
• W2015241478 cites W2161198425 @default.
• W2015241478 cites W2161405800 @default.
• W2015241478 cites W2165407899 @default.
• W2015241478 cites W2168315834 @default.
• W2015241478 doi "https://doi.org/10.1089/thy.2013.0698" @default.
• W2015241478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4080868" @default.
• W2015241478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24702238" @default.
• W2015241478 hasPublicationYear "2014" @default.
• W2015241478 type Work @default.
• W2015241478 sameAs 2015241478 @default.
• W2015241478 citedByCount "70" @default.
• W2015241478 countsByYear W20152414782014 @default.
• W2015241478 countsByYear W20152414782015 @default.
• W2015241478 countsByYear W20152414782016 @default.
• W2015241478 countsByYear W20152414782017 @default.
• W2015241478 countsByYear W20152414782018 @default.
• W2015241478 countsByYear W20152414782019 @default.
• W2015241478 countsByYear W20152414782020 @default.
• W2015241478 countsByYear W20152414782021 @default.
• W2015241478 countsByYear W20152414782022 @default.
• W2015241478 countsByYear W20152414782023 @default.
• W2015241478 crossrefType "journal-article" @default.
• W2015241478 hasAuthorship W2015241478A5008264035 @default.
• W2015241478 hasAuthorship W2015241478A5009821445 @default.
• W2015241478 hasAuthorship W2015241478A5009926546 @default.
• W2015241478 hasAuthorship W2015241478A5014123674 @default.
• W2015241478 hasAuthorship W2015241478A5017766225 @default.
• W2015241478 hasAuthorship W2015241478A5027823950 @default.
• W2015241478 hasAuthorship W2015241478A5038586420 @default.
• W2015241478 hasAuthorship W2015241478A5042156102 @default.
• W2015241478 hasAuthorship W2015241478A5043036621 @default.
• W2015241478 hasAuthorship W2015241478A5046084794 @default.
• W2015241478 hasAuthorship W2015241478A5055086811 @default.
• W2015241478 hasAuthorship W2015241478A5068090112 @default.
• W2015241478 hasAuthorship W2015241478A5068561297 @default.
• W2015241478 hasAuthorship W2015241478A5069110450 @default.
• W2015241478 hasAuthorship W2015241478A5075362203 @default.
• W2015241478 hasAuthorship W2015241478A5078350860 @default.
• W2015241478 hasAuthorship W2015241478A5085467485 @default.
• W2015241478 hasBestOaLocation W20152414782 @default.
• W2015241478 hasConcept C126322002 @default.
• W2015241478 hasConcept C143998085 @default.
• W2015241478 hasConcept C159654299 @default.
• W2015241478 hasConcept C163764329 @default.
• W2015241478 hasConcept C167135981 @default.
• W2015241478 hasConcept C203014093 @default.
• W2015241478 hasConcept C2777074255 @default.
• W2015241478 hasConcept C2778696486 @default.
• W2015241478 hasConcept C2778835679 @default.
• W2015241478 hasConcept C2779134260 @default.
• W2015241478 hasConcept C2779761222 @default.
• W2015241478 hasConcept C2781461381 @default.
• W2015241478 hasConcept C50181227 @default.

• next